Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06932029 · ClinicalTrials.gov registry record · NA

SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases

A NA study of Hypertension, sponsored by Korey Kennelty.

Recruiting
Registry status
NA
Development phase
930
Enrollment target
2
Study locations

NCT06932029 is a NA study of Hypertension that is actively recruiting participants, run by Korey Kennelty. The registered enrollment target is 930 participants, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (73% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06932029, a NA study of Hypertension, is actively recruiting participants, sponsored by Korey Kennelty.

RECRUITING
Registry status
NA
Development phase
930 participants
Enrollment target
2
Study locations

Study Summary

Nearly half of adults in the United States (47 percent, or 116 million) have hypertension, also known as high blood pressure (BP). Uncontrolled high BP can be devasting as it can lead to stroke, heart attack and kidney failure, as well as other numerous health conditions. Hypertension can be controlled; however, only one in four of adults with hypertension have their BP controlled. The chance of having high BP increases as one ages, requiring the need to examine effective hypertension strategies in older adults. The issue of hypertension management is compounded even further among older U.S. adults who live with multiple chronic diseases. National organizations identified several effective health systems strategies for improving rates of BP control, including patient self-measured blood pressure (SMBP) monitoring. SMBP involves a patient's regular use of personal BP monitoring devices to assess and record BP across different points in time, typically at home. The evidence base for utilizing SMBP strategies in healthcare systems and practices is strong. However, there is not research regarding SMBP including how to include it into workflow in primary care clinics. Previous research has shown SMBP is beneficial, but more information is needed regarding whether SMBP is beneficial in high-risk populations (such as rural, older adults or Black, older patients). The research team will test whether SMBP with normal clinical support vs SMBP with clinical pharmacist support improves BP in older adults living with multiple chronic conditions. The addition of a pharmacist has been shown to improve patient outcomes, though the effectiveness of SMBP with a clinical pharmacist in older adults is not known. The primary outcome will be change in systolic BP over 12 months. The secondary outcome will be self-reported treatment burden over 12 months, using a validated tool called the Multimorbidity Treatment Burden Questionnaire. The research team plans to include a subgroup of rur

Conditions Studied

Interventions

  • BEHAVIORAL SMBP with clinical pharmacist support

Study Locations (2)

Iowa

  • University of Iowa Health Care - Iowa City
  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 930 participants
Start Date 2025-07-01
Est. Completion 2031-05-01
Phase NA

Sponsor

Korey Kennelty

5 total trials

What the Registry Record Tells You About NCT06932029

The ClinicalTrials.gov registry entry for NCT06932029 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 930 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,505-participant average among 470 other Hypertension trials with a reported enrollment target (73% lower). The listed sponsor is Korey Kennelty, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which SMBP with clinical pharmacist support is the first listed.

NCT06932029 reports 2 study locations spanning 1 distinct geographic area - top geographies include Iowa.

Frequently Asked Questions

What is clinical trial NCT06932029 about?

NCT06932029 is a clinical study titled "SMBP Study: Improving High Blood Pressure in Older Adults With Multiple Chronic Diseases". Nearly half of adults in the United States (47 percent, or 116 million) have hypertension, also known as high blood pressure (BP). Uncontrolled high BP can be devasting as it can lead to stroke, heart attack and kidney failure, as well as other numerous health conditions. Hypertension can be control...

What is the current status of trial NCT06932029?

This trial is currently recruiting. It is a NA study. The enrollment target is 930 participants. The study started on 2025-07-01. Estimated completion is 2031-05-01.

What conditions does trial NCT06932029 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT06932029?

The interventions under investigation include: SMBP with clinical pharmacist support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06932029?

This trial is sponsored by Korey Kennelty, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06932029 being conducted?

This trial has 2 study locations across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.